

Antiallergic.
Pharmacological properties:
Pharmacokinetics:
The active substance Azelastine hydrochloride.
Azelastine is marketed under different brands and generic names, and comes in different dosage forms:
Brand name | Manufacturer | Country | Dosage form |
---|---|---|---|
Allergodil® | Meda Pharma GmbH & Co. KG | Switzerland | eye drops |
Allergodil® | Meda Pharma GmbH & Co. KG | Switzerland | spray |
No customer reviews for the moment.
Seasonal allergic conjunctivitis:
Off-season (year-round) allergic conjunctivitis:
Duration of use - no more than 6 weeks.
The incidence of side effects is defined as follows:
Very often:> 1/10;
Often: <1/10> 1/100;
Infrequently: <1/100> 1/1000;
Rarely: <1/1000> 1/10000;
Very rare: <1/10000.
Local:
Are common:
Not found. In the case of concomitant therapy with other eye drops, you should bury them in the eyes with an interval of at least 15 minutes.
Use in the first trimester of pregnancy is not recommended, and in the second and third trimesters and during lactation it is possible if the possible benefit for the mother exceeds the risk for the fetus / child.
When using eye drops it is not recommended to wear contact lenses.
Impact on the ability to drive. In case of blurring of vision immediately after instillation of the drug, one should refrain from driving and engaging in activities requiring increased attention until it is restored.
Data overdose of the drug is not available.
Studies and clinical trials of Azelastine (Click to expand)